Lila Bio
Lila Bio is a biotechnology company leveraging AI-powered protein design to develop breakthrough therapeutics for oncology and non-oncology indications. Their approach combines deep understanding of disease biology with their proprietary AI engine, LILADDTM, to discover and optimize molecules with differentiated target product profiles. They focus on developing Targeted RadioTherapy (TRT) for solid tumors and Long-Acting Injectables (LAI) for non-oncology indications, aiming for bespoke pharmacology, robust chemistries, tailored pharmacokinetics, and optimized developability. The company is built on a team of experienced scientists and biotech professionals with a proven track record, and they have established collaborations with major entities like Eli Lilly.
Lila Bio
Lila Bio is a biotechnology company leveraging AI-powered protein design to develop breakthrough therapeutics for oncology and non-oncology indications. Their approach combines deep understanding of disease biology with their proprietary AI engine, LILADDTM, to discover and optimize molecules with differentiated target product profiles. They focus on developing Targeted RadioTherapy (TRT) for solid tumors and Long-Acting Injectables (LAI) for non-oncology indications, aiming for bespoke pharmacology, robust chemistries, tailored pharmacokinetics, and optimized developability. The company is built on a team of experienced scientists and biotech professionals with a proven track record, and they have established collaborations with major entities like Eli Lilly.